Advertisment
ECCO 2016: Professor David Rubin (Chicago, USA), Dr Charlie Lees (Edinburgh, UK) and Dr Peter Irving (London, UK) discuss when to cycle biologics within class and when to switch classes for patients failing on anti-TNF therapy.

Advertisment